| Name | Title | Contact Details |
|---|
At Dart NeuroScience we are visionaries` innovators` and optimists. We are not a typical pharmaceutical company. We are a discovery catalyst` perfectly positioned and structured to make a serious difference in our world. Curious and creative` hopeful and driven – all joined together to fulfill our vision: protect and enhance the quality of mind. With open minds and open hearts` we stretch our limits every day so that we can continue to improve life and the way we live it.
EMR Experts, Inc is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
First Choice Healthcare is a Macon, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded nearly 50 years ago and employing over 2,500 clinical, regulatory, and operational pharmacy professionals, Comprehensive Pharmacy Services is the nation`s oldest and largest provider of pharmacy support services to more than 700 hospitals and healthcare facilities across the United States and Puerto Rico. CPS helps hospital pharmacists tackle complex problems such as medication reconciliation, hyper-inflated drug costs, standardization, centralized distribution, regulatory & compliance, and 340B programs leading to increased quality, reduced admissions and lower costs. Services provided by CPS include pharmacy management, pharmacy consulting, specialized pharmacy services, telepharmacy, 340B program compliance assurance, ambulatory & retail pharmacy services, medication related transition of care, and pharmacy analytics.
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.